Sailesh Patel

Cohance Lifesciences is a global, merchant API platform. With 8 manufacturing units (including 5 USFDA approved units) and 2 R&D dedicated units, we serve our marquee clients as partner of choice in a range of niche Intermediates, API, Pharmaceutical Formulation intermediates (PFI), Formulations & Speciality chemicals across both Innovator and Generic molecules. We also specialise in highly specialised CRAMS and Clinical research. As a global player, we have presence in 60 countries and have a growing product basket of 80+ molecules backed by robust R&D and Infrastructure.